EKO International Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EKNL research report →
Price Chart
About the company
Headquartered in Burlington, Canada, EKO International Corp. operates via its joint venture with NeuroVasc Clinical Inc. This partnership is responsible for the marketing and supply of frequency rhythmic electrical modulation system (FREMS) equipment throughout Canada, used in addressing peripheral neuropathy.
- CEO
- Rocky DiBenedetto
- IPO
- 1997
- Employees
- 8
- HQ
- Burlington, ON, CA
Get TickerSpark's AI analysis on EKNL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.34K
- P/E
- 0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.86
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 386.14%
- ROIC
- 34.17%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-692,956+0.0%
- Op Income
- $-725,284
- Net Income
- $-801,504+0.0%
- EPS
- $0.00+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 8.08
- RSI (14)
- 100
- Avg Volume
- 6
No earnings-call transcripts are available for EKNL yet.
- Free Float
- 75.3%
- Shares Outstanding
- 31.68M
- Float Shares
- 23.87M
Our EKNL coverage
Recent articles, reports, and earnings notes.
No research on EKNL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EKNL report →